UBS AM’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Buy |
227,627
+101,845
| +81% | +$6.44M | ﹤0.01% | 1176 |
|
|
2025
Q1 | $6.66M | Sell |
125,782
-92,762
| -42% | -$4.91M | ﹤0.01% | 1417 |
|
|
2024
Q4 | $12.2M | Sell |
218,544
-6,829
| -3% | -$382K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $11.8M | Sell |
225,373
-11,058
| -5% | -$579K | ﹤0.01% | 1149 |
|
|
2024
Q2 | $9.71M | Buy |
236,431
+29,451
| +14% | +$1.21M | ﹤0.01% | 1150 |
|
|
2024
Q1 | $8.97M | Sell |
206,980
-2,958
| -1% | -$128K | ﹤0.01% | 1044 |
|
|
2023
Q4 | $9.65M | Sell |
209,938
-127,326
| -38% | -$5.85M | ﹤0.01% | 996 |
|
|
2023
Q3 | $7.73M | Buy |
337,264
+131,229
| +64% | +$3.01M | ﹤0.01% | 1041 |
|
|
2023
Q2 | $3.68M | Hold |
206,035
| – | – | ﹤0.01% | 1372 |
|
|
2023
Q1 | $3.68M | Buy |
206,035
+163,838
| +388% | +$2.92M | ﹤0.01% | 1372 |
|
|
2022
Q4 | $1.23M | Buy |
42,197
+12,260
| +41% | +$357K | ﹤0.01% | 1754 |
|
|
2022
Q3 | $733K | Sell |
29,937
-24,886
| -45% | -$610K | ﹤0.01% | 2145 |
|
|
2022
Q2 | $228K | Buy |
54,823
+25,392
| +86% | +$105K | ﹤0.01% | 2553 |
|
|
2022
Q1 | $339K | Hold |
29,431
| – | – | ﹤0.01% | 2565 |
|
|
2021
Q4 | $294K | Buy |
29,431
+4,216
| +17% | +$42.1K | ﹤0.01% | 2682 |
|
|
2021
Q3 | $329K | Hold |
25,215
| – | – | ﹤0.01% | 2601 |
|
|
2021
Q2 | $494K | Buy |
25,215
+14,719
| +140% | +$288K | ﹤0.01% | 2543 |
|
|
2021
Q1 | $223K | Sell |
10,496
-18,630
| -64% | -$396K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $866K | Sell |
29,126
-2,838
| -9% | -$84.4K | ﹤0.01% | 2062 |
|
|
2020
Q3 | $693K | Buy |
31,964
+12,901
| +68% | +$280K | ﹤0.01% | 1990 |
|
|
2020
Q2 | $425K | Buy |
+19,063
| New | +$425K | ﹤0.01% | 2183 |
|